System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Gwenael Ferron is an expert in Oncology at Oncopole Claudius Regaud (France). As of October 2026, ScienceLeadR ranks Gwenael Ferron in the top 1% of experts worldwide for Ovarian Neoplasms, Adnexal Diseases and Gonadal Disorders. Gwenael Ferron has authored 395 publications, the most recent in 2026, and is an investigator in 16 clinical trials, 4 of them ongoing. SLR score: 1,115 (community average: 125). How the SLR is computed.

LeadR Profile

Gwenael Ferron Oncopole Claudius Regaud France
1 115 ScienceLeadR Reputation 1115

Unlock

Register Login
Network Map

Oncology

Subspecialties: Gynecology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2003 - 2026
Source: PubMed

Arcagy Gineco

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 395

Citations

Citations: 8 161 1st author: 23 Last author: 52 Unique author: 0

Main journals

Int J Gynecol Cancer 70
Gynecol Oncol 30
J Clin Oncol 24
Bull Cancer 22
Ann Oncol 18

Best Journals

J Clin Oncol 15
Ann Oncol 4
N Engl J Med 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Approach to the hepato-gastric region in gynecological malignancies.
PMID 42414127 — genital neoplasms, female		Int J Gynecol Cancer20260
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG network.
PMID 42411723 — cytoreduction surgical procedures, ovary, neoplasms, ovarian neoplasms		J Gynecol Oncol20260
Adjuvant Chemotherapy and Survival After Pelvic Exenteration for Gynecologic Cancers in the COREPEX Study.
PMID 42360748 — pelvic exenteration, drug therapy, chemotherapy, adjuvant, chemotherapy		JAMA Netw Open20261
Validation of the Transcription Association Chromosomal Instability Index Biomarker on RNA Sequencing in Soft Tissue Sarcomas.
PMID 42308462 — neoplasms, biomarkers, sarcoma, precision medicine, therapeutics, tissues, chromosomal instability, prognosis, rna		JCO Precis Oncol20260
Overall survival of patients with localized soft tissue sarcoma treated with or without adjuvant chemotherapy (DEEPSARC): a real world nationwide retrospective cohort study in France.
PMID 42291149 — registries, cohort studies, drug therapy, sarcoma, chemotherapy, adjuvant, work, therapeutics, tissues, aids-related complex, chemotherapy		EClinicalMedicine20263

Clinical Studies 16

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 10
Phase 3 4
Phase 1 1
Phase 2 1

By status:

Completed 7
Recruiting 4
Active not recruiting 3
Not yet recruiting 1
Unknown 1

By type:

Interventional 15
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 14

Main Topics

Cohort/Consortium Investigators 6

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
SALVOVAR trial A pragmatic randomized phase III trial to assess the utility of adjusting chemotherapy dose dosing schedule with the SALVage weekly dose dense regimen in patients with poor prognostic OVARian cancers based on the tumor unfavorable primary chemosensitivity and incomplete debulking surgery
2023-508260-30-01 — paclitaxel, ovary, neoplasms, drug therapy, ovarian neoplasms, carboplatin, chemotherapy		Phase 3Recruiting2024
Risk reducing Strategies Including Fimbriectomy in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer
NCT06726330 — sterilization, menopause, premature, surgical procedures, operative, genetic predisposition to disease, ovary, cardiovascular diseases, neoplasms, cognitive dysfunction, sterilization, tubal, germ-line mutation, osteoporosis, ovarian neoplasms, patient preference, prophylactic surgical procedures, menopause, tissues, genes, brca1, salpingo-oophorectomy, mutation, pelvic neoplasms, fallopian tubes, ovariectomy, carcinoma, women		N/ANot yet recruiting2027
Utility of Adjusting Chemotherapy Dose Dosing Schedule With the SALVage Weekly Dose dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery
NCT06476184 — area under curve, paclitaxel, ovary, neoplasms, drug therapy, chemotherapy, adjuvant, ovarian neoplasms, carboplatin, chemotherapy		Phase 3Recruiting2024
PARa aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT05581121 — radiotherapy, carcinoma, adenosquamous, lymph nodes, lymph node excision, uterine cervical neoplasms, brachytherapy, neoplasms, adenocarcinoma, laparoscopy, human papillomavirus 16, lymph, therapeutics, carcinoma		Phase 3Recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS